Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Recent developments in certain X-linked genetic eye disorders

B S Shastry1

  • 1Eye Research Institute of Oakland University, Rochester, MI 48309-4401.

Biochimica Et Biophysica Acta
|September 8, 1993
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Magnetic Ground States of the Rare-Earth Tripod Kagome Lattice Mg_{2}RE_{3}Sb_{3}O_{14} (RE=Gd,Dy,Er).

Physical review letters·2016
Same author

Extremely correlated Fermi-liquid description of normal-state ARPES in cuprates.

Physical review letters·2011
Same author

Evaluation of the CYP1B1 gene as a candidate gene in beagles with primary open-angle glaucoma (POAG).

Molecular vision·2009
Same author

Autosomal recessive primary open angle glaucoma (POAG) in beagles is not associated with mutations in the myocilin (MYOC) gene.

Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie·2009
Same author

Assessment of the contribution of insulin-like growth factor I receptor 3174 G-->A polymorphism to the progression of advanced retinopathy of prematurity.

European journal of ophthalmology·2007
Same author

Pharmacogenetics and the concept of individualized medicine.

The pharmacogenomics journal·2005
Same journal

Cumulative Contents.

Biochimica et biophysica acta·2020
Same journal

Molecular Basis of Disease Cumulative Contents.

Biochimica et biophysica acta·2020
Same journal

General Subjects Cumulative Contents.

Biochimica et biophysica acta·2020
Same journal

Erratum to 'on the role of exchangeable hydrogen bonds for the kinetics of P680<sup>+·</sup> Q<sub>A</sub> <sup>-·</sup> formation and P680<sup>+·</sup> Pheo<sup>-·</sup> recombination in photosystem II' [Biochim. Biophys. Acta 1276 (1996) 35-44].

Biochimica et biophysica acta·2019
Same journal

Oligomeric state of the light-harvesting complexes B800-850 and B875 from purple bacterium Rubrivivax gelatinosus in detergent solution.

Biochimica et biophysica acta·2019
Same journal

Regulation of pigment content and enzyme activity in the cyanobacterium Nostoc sp. Mac grown in continuous light, a light-dark photoperiod, or darkness.

Biochimica et biophysica acta·2019
See all related articles

Advances in recombinant DNA and somatic cell genetics have significantly improved our understanding of genetic eye diseases. This progress enables new diagnostic and therapeutic approaches for vision disorders.

Area of Science:

  • Ophthalmology
  • Genetics
  • Molecular Biology

Background:

  • Genetic eye diseases are a rapidly advancing research area in vision science.
  • Recombinant DNA and somatic cell genetics have driven progress in identifying genetic defects.
  • Understanding genetic eye disorders has been significantly enriched by recent molecular studies.

Purpose of the Study:

  • To highlight developments in genetic eye diseases, focusing on X-linked disorders.
  • To provide beginners and a general audience with clinical pathology and molecular probe information.
  • To present genetic disorders in a structured, chromosomal linkage-based format.

Main Methods:

  • Localization and characterization of human disease genes.
  • Utilizing molecular probes to identify genetic defects.

Related Experiment Videos

  • Reviewing clinical pathology and genetic linkage data for X-linked eye diseases.
  • Main Results:

    • Numerous genetic disease genes have been localized and characterized.
    • Molecular analyses reveal ongoing challenges in genetic eye disorder research.
    • Initial developments in understanding X-linked genetic eye diseases are presented.

    Conclusions:

    • Gene replacement therapy, prenatal diagnosis, and carrier detection are now feasible for genetic eye diseases.
    • Molecular insights provide a foundation for future research and clinical applications.
    • The report serves as a valuable resource for researchers and ophthalmologists in the field.